Back to the main directory
EarningsReview / Equity
- Wrapping up a year of significant change by BNP Paribas Exane
- A beat with cautious guidance: results first take by BNP Paribas Exane
- In the Flow by BNP Paribas Exane
- 4Q24 first take: 6% adj EBITDA beat; 2025 profit guide in line, capex trimmed by BNP Paribas Exane
- Medical tourism dips further in Dec-24; freight services to Bangladesh resumes after several months by BNP Paribas Exane
- 2025 guidance released; new 2027 mid-term plan with upside to consensus by BNP Paribas Exane
- Freelance.com - Un environnement qui reste compliqué by MidCap Partners
- H224 results: Guidance on the underwhelming side by BNP Paribas Exane
- FY24: earnings in line but no upgrade to guidance by BNP Paribas Exane
- 4Q24 sales/EBIT 5%/2% above cons. US volume growing. FY25 guide in-line on sales, HSD above on EBIT by BNP Paribas Exane
- ROVI: RDOS. 4T’24 (ANÁLISIS BANCO SABADELL) by Sabadell
- AAL, US SCRAP, CLF, CBAM, STEEL US, OUT1V by BNP Paribas Exane
- Q424 conf call: A two year volume recovery, focused on execution in the meantime by BNP Paribas Exane
- Orsted sellside breakfast feedback by BNP Paribas Exane
- 4Q24 pre-call takeaways by BNP Paribas Exane
- FY24: Value on show, growth (still) underestimated by BNP Paribas Exane
- FQ4’25: Growth still pedestrian, but stable by BNP Paribas Exane
- 2025 guidance broadly inline by BNP Paribas Exane
- Itaú BBA on Marcopolo: Better than Anticipated Top Line and EBITDA Overshadowed by a Profitability Miss in 4Q24 by Itau
- Air Liquide - MARGINS DEFYING GRAVITY by Equita Sim
- by BNP Paribas Exane
- Trip.com Group (TCOM US) by HSBC
- CMD next week - what to expect? by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane